• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum

    10/17/25 7:00:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology
    Get the next $DH alert in real time by email

    New York City, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) --





    Salubrum, a vertical artificial intelligence (AI) company, has launched a category-defining commercialization engine for healthcare growth. In an industry where legacy agencies struggle to scale, Salubrum's AI-first approach productizes and automates the traditional marketing agency. Salubrum has partnered with industry giant Definitive Healthcare (NASDAQ:DH) to provide best-in-class precision patient activation, reimagining how healthcare brands go to market.



    Origins of Salubrum

    Founded by first-generation Canadian entrepreneur Osama Usmani, Salubrum was initially focused on medical tourism. However, Usmani quickly recognized that the issue in healthcare wasn't a lack of providers, but poor commercialization. Essentially, providers were invisible to their patients, not inaccessible. Leveraging his experience as a management consultant at Deloitte, Usmani, along with his team of experts, got to work on building a new way to connect patients and providers.

    A New Way of Finding Patients

    The team behind Salubrum found that healthcare providers struggle to acquire patients online due to a lack of access to data, workflows, and tools needed to capitalize on growing demand. By building its AI engine, Salubrum sifts through low-quality search results, generic ads, and unsafe options, showcasing healthcare providers to real, high-intent patients, building trust and access.



    "After speaking to patients and providers in 2024, Salubrum evolved into a vertical AI company focused on creating real demand activation for healthcare brands," Usmani stated. "The goal: unlock access for patients and growth for providers; starting with 1:1 targeting, expanding into a full commercialization platform."

    True Vertical Specialization

    Salubrum is pushing for true vertical specialization, in contrast to generalist tools. Its AI is trained to optimize the rules, compliance, data, and key performance indicators (KPIs) unique to healthcare. As such, it aims to be capable of automating the agency stack, disintermediate legacy models, and achieve domain defensibility through data and logic. Through bold leadership, quick execution, and innovative partnerships, Salubrum is realizing its goals.



    "Salubrum isn't a GPT wrapper or a marketplace," Usmani continued, "we're building a vertical AI company for healthcare commercialization. Our mission: productize healthcare growth so that legacy service models become obsolete."

    Displacing Traditional Agencies

    As Salubrum's vertical AI solution is positioned to displace agencies across the healthcare industry, the company has found opportunities to enter into partnerships. Today, Salubrum, backed by its lead investor, Forum Ventures, has begun a strategic data alliance with Definitive Healthcare (NASDAQ:DH) and is supported by former NBA Player turned Venture Capitalist, Metta World Peace, and former executives from Klick Health and MoneyGram. Perhaps most notably, the early-stage startup recently reached $60,000 USD in ARR and has achieved a $2M USD valuation.  

    Building the Future of Healthcare Growth

    Salubrum aims to build the future of healthcare marketing, defining a new category of agentic brand growth. Its vertical AI tool supports businesses in automating entire workflows and outperforming traditional agencies. Since Salubrum's solution is trained on proprietary datasets, it is able to achieve true 1:1 programmatic advertising. This service is known as creme de la creme when it comes to marketing, but better yet, due to the Salubrum productizing so much manual work, it is able to offer this usually expensive service to the SME market, marking a true inflection point in the marketing world.

    About Salubrum

    Salubrum is a vertical AI-powered commercialization partner for healthcare brands that prioritizes patient activation. The company's goal is to shift the industry away from legacy agencies and help healthcare brands get discovered, ensuring long-term visibility through data science. Ultimately, Salubrum is building commercialization infrastructure, more than just advertisement.



    Salubrum is backed by New York City-based Forum Ventures, supported by Toronto-based NEXT Canada, and Los Angeles-based Artest Management Group.







    Osama Usmani
    osama(at)salubrum.com

    Primary Logo

    Get the next $DH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DH

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    1/13/2025$4.00Equal Weight → Underweight
    Barclays
    12/20/2024$5.00Equal-Weight
    Stephens
    9/17/2024$7.00Buy
    BTIG Research
    7/31/2024$7.00 → $5.00Neutral → Underweight
    JP Morgan
    5/8/2024$11.50 → $9.00Overweight → Equal-Weight
    Morgan Stanley
    1/17/2024Buy → Hold
    Needham
    1/5/2024Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $DH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Definitive Healthcare downgraded by BTIG Research

    BTIG Research downgraded Definitive Healthcare from Buy to Neutral

    5/9/25 8:41:31 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare downgraded by Barclays with a new price target

    Barclays downgraded Definitive Healthcare from Equal Weight to Underweight and set a new price target of $4.00

    1/13/25 7:41:23 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Stephens initiated coverage on Definitive Healthcare with a new price target

    Stephens initiated coverage of Definitive Healthcare with a rating of Equal-Weight and set a new price target of $5.00

    12/20/24 7:31:03 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum

    New York City, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Salubrum, a vertical artificial intelligence (AI) company, has launched a category-defining commercialization engine for healthcare growth. In an industry where legacy agencies struggle to scale, Salubrum's AI-first approach productizes and automates the traditional marketing agency. Salubrum has partnered with industry giant Definitive Healthcare (NASDAQ:DH) to provide best-in-class precision patient activation, reimagining how healthcare brands go to market. Origins of Salubrum Founded by first-generation Canadian entrepreneur Osama Usmani, Salubrum was initially focused on medical tourism. However, Usmani quickly recognized that

    10/17/25 7:00:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

    FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief Financial Officer, Casey Heller, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference. The Definitive Healthcare presentation is scheduled for Tuesday, September 9, 2025, at 9:15 a.m. Eastern Time. A live webcast of the presentation will be available on the Events page of the Definitive Healthcare investor relations website at https://ir.definitivehc.com/. A replay of the webcast will also be available for a limited tim

    9/2/25 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025

    FRAMINGHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2025.  Second Quarter 2025 Financial Highlights: Revenue was $60.8 million, a decrease of 5% from $63.7 million in Q2 2024. Net Loss was $(9.3) million, or (15)% of revenue, compared to $(306.2) million in Q2 2024, inclusive of goodwill impairment charges of $363.6 million, or (480)% of revenue.Adjusted Net Income was $9.7 million, compared to $14.2 million in Q2 2024.Adjusted EBITDA was $18.7 million, or 31% of revenue, compared to

    8/7/25 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Heller Casey covered exercise/tax liability with 8,300 shares, decreasing direct ownership by 0.76% to 1,081,421 units (SEC Form 4)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    10/3/25 8:23:35 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Coop Kevin covered exercise/tax liability with 37,593 shares, decreasing direct ownership by 1% to 3,584,788 units (SEC Form 4)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    10/3/25 8:20:47 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    EXECUTIVE CHAIRMAN Krantz Jason Ronald covered exercise/tax liability with 4,093 shares, decreasing direct ownership by 0.38% to 1,079,380 units (SEC Form 4)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    9/16/25 4:05:59 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    SEC Filings

    View All

    SEC Form 10-Q filed by Definitive Healthcare Corp.

    10-Q - Definitive Healthcare Corp. (0001861795) (Filer)

    8/7/25 4:23:27 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Definitive Healthcare Corp. (0001861795) (Filer)

    8/7/25 4:13:26 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 8-K filed by Definitive Healthcare Corp.

    8-K - Definitive Healthcare Corp. (0001861795) (Filer)

    7/23/25 5:18:29 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Leadership Updates

    Live Leadership Updates

    View All

    Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth

    FRAMINGHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Kevin Coop as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective June 24, 2024. Mr. Coop succeeds Jason Krantz, founder and Executive Chairman, who has been serving as Interim CEO since January 2024. Mr. Krantz will continue to serve on the Board of Directors as Executive Chairman after the CEO transition. "Kevin is an outstanding leader. He has deep, hands-on experience with data-focused businesses and has a

    5/28/24 8:00:00 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors

    Jim Emling, the CEO of Datassential and former long-time president of Milwaukee-based Zywave, has been appointed Executive Chair of the Board of Directors at VBA, the company announced today. "We are delighted to welcome Jim officially to VBA as the Executive Chair," said Michael Clayton, the company's President and CEO. "Jim and I have worked closely together over the last 3 months and his decades of experience scaling high growth software companies combined with his strong ties to the Milwaukee technology sector will be tremendous assets to VBA as we enter our next phase of growth." Emling has deep roots in the Milwaukee technology community. He was the founding CTO of Zywave and serv

    11/28/23 5:00:00 PM ET
    $DH
    $GDRX
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer

    FRAMINGHAM, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023. "I am thrilled to welcome Carrie Lazorchak to Definitive Healthcare as our new Chief Revenue Officer," said Robert Musslewhite, Chief Executive Officer of Definitive Healthcare. "Carrie is a fantastic fit for Definitive Healthcare. Her values and her deep belief in the power of humble collaboration make her a perfect match for our culture. Carrie brings a wealth of experience selling Software as a Service to both enterprise accounts and

    10/5/23 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Financials

    Live finance-specific insights

    View All

    Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025

    FRAMINGHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2025.  Second Quarter 2025 Financial Highlights: Revenue was $60.8 million, a decrease of 5% from $63.7 million in Q2 2024. Net Loss was $(9.3) million, or (15)% of revenue, compared to $(306.2) million in Q2 2024, inclusive of goodwill impairment charges of $363.6 million, or (480)% of revenue.Adjusted Net Income was $9.7 million, compared to $14.2 million in Q2 2024.Adjusted EBITDA was $18.7 million, or 31% of revenue, compared to

    8/7/25 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast

    FRAMINGHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortl

    7/24/25 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

    FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.  First Quarter 2025 Financial Highlights: Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024. Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(155.1) million, or (262)% of revenue, compared to $(12.7) million or (20)% of revenue in Q1 2024.  Adjusted Net Income was $7.0 million, compared to $13.0 million in Q1 2024.   Adjusted EBITDA was $14.7 million, or 25% of revenue, compar

    5/8/25 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Definitive Healthcare Corp.

    SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)

    11/12/24 11:54:03 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Definitive Healthcare Corp.

    SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)

    10/3/24 9:08:57 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Definitive Healthcare Corp. (Amendment)

    SC 13G/A - Definitive Healthcare Corp. (0001861795) (Subject)

    2/14/24 4:00:33 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology